Blood cells and chronic myelomonocytic leukemia study
Part of Blood & lymphatic, Cancer clinical trials.
This research study examines blood cells from patients with chronic myelomonocytic leukemia (CMML), a rare blood cancer, to better understand how the disease develops and progresses. By studying your blood cells, researchers hope to learn more about what causes CMML and how to treat it better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been newly diagnosed with CMML or are currently receiving treatment for CMML
- You are a patient at one of the participating hospital hematology (blood disease) departments
- You are willing to provide blood samples for research purposes
- You are able to consent to participate in the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at certain proteins in the blood (called FLT3 ligand and IL6) of people being treated for blood cancers like AML, MDS, or CMML. The goal is to understand how these proteins change during non-intensive chemotherapy, which may help doctors better personalize treatment.
This study collects information from people diagnosed with chronic lymphatic leukemia. It may help doctors better understand the disease, track patient needs, and improve future care.
This research study collects information from adults with chronic myelomonocytic leukemia (CMML), a rare blood cancer where the body makes too many monocytes (a type of white blood cell). By following patients over time, researchers aim to better understand the disease and improve treatments.
This study looks at how a type of white blood cell (monocyte) affects myeloproliferative neoplasms, a group of blood cancers. It aims to help doctors better understand these diseases and improve treatment.
This study is for adults with acute myeloid leukemia (AML) whose cancer has returned or is not responding to treatment. Researchers will analyze your leukemia cells to learn more about the disease and possibly find better treatments.
This study looks at what leads to specific blood cancers and related blood disorders. If you have one of the listed conditions (or are being evaluated for it), you may be asked to join research that helps doctors understand why these illnesses happen.
Hear when a new Chronic Myelomonocytic Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.